Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DLC7Y9
|
|||
| Drug Name |
Bezuclastinib
|
|||
| Synonyms |
Bezuclastinib; CGT9486; PLX-9486; 2ROQ545LAG; PLX9486; CGT-9486; 1616385-51-3; UNII-2ROQ545LAG; PLX 9486 [WHO-DD]; 4,5-dimethyl-N-(2-phenyl-1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazole-3-carboxamide; 3,4-Dimethyl-N-(2-phenyl-1H-pyrrolo(2,3-b)pyridin-5-yl)-1H-pyrazole-5-carboxamide; 3,4-dimethyl-N-(2-phenyl-1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazole-5-carboxamide; Bezuclastinib [WHO-DD]; BEZUCLASTINIB [INN]; BEZUCLASTINIB [USAN]; CHEMBL5095229; SCHEMBL15824576; GTPL11868; NVSHVYGIYPBTEZ-UHFFFAOYSA-N; BDBM392363; GLXC-26827; EX-A5975; US10301280, Compound P-2007; US10301280, Compound P-2164; MS-24986; HY-145557; CS-0376032; 1H-Pyrazole-3-carboxamide, 4,5-dimethyl-N-(2-phenyl-1H-pyrrolo[2,3-b]pyridin-5-yl)-; 3,4-dimethyl-N-(2-phenyl-1H- pyrrolo[2,3-b]pyridin-5-yl)-1H- pyrazole-5-carboxamide; WEJ
Click to Show/Hide
|
|||
| Drug Type |
Small molecule
|
|||
| Indication | Gastrointestinal stromal tumour [ICD-11: 2B5B] | Phase 3 | [1] | |
| Company |
Cogent Biosciences
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H17N5O
|
|||
| Canonical SMILES |
CC1=C(NN=C1C(=O)NC2=CN=C3C(=C2)C=C(N3)C4=CC=CC=C4)C
|
|||
| InChI |
InChI=1S/C19H17N5O/c1-11-12(2)23-24-17(11)19(25)21-15-8-14-9-16(22-18(14)20-10-15)13-6-4-3-5-7-13/h3-10H,1-2H3,(H,20,22)(H,21,25)(H,23,24)
|
|||
| InChIKey |
NVSHVYGIYPBTEZ-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | KIT D816V mutant (KIT D816V) | Target Info | Inhibitor | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05208047) A Phase 3 Randomized, Open-Label, Multicenter Clinical Study of CGT9486+Sunitinib vs. Sunitinib in Subjects With Locally Advanced, Unresectable, or Metastatic Gastrointestinal Stromal Tumors. U.S.National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of Cogent Biosciences | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.